---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-093565"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-08-25T21:00:14+00:00"
generated_at: "2026-08-25T21:01:17.486465+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BiomX shareholders approve Dr. Frucht issuance, reverse split, auditor ratification

## Summary
- Approved issuance of shares to Mandragola Ltd. for Dr. Frucht Systems acquisition: 9,313,228 for, 429,645 against.
- Approved reverse stock split of 1-for-5 to 1-for-20; authorized shares cut from 750M to 150M.
- Ratified Barzily & Co. as independent auditor for FY2026: 9,575,900 for.
- Quorum reached with 9,813,430 shares (36.9% of 26,559,607 outstanding); adjournment not needed.

## SEC filing metadata
- accession: 0001213900-26-093565
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-08-25T21:00:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026093565/0001213900-26-093565-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026093565/ea0303308-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-093565
- JSON: https://secwatch.observer/filing/0001213900-26-093565.json
- Plain text: https://secwatch.observer/filing/0001213900-26-093565.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.